Bioanalytical Systems Inc. (BASI)
Symbol Info
Listed Symbol BASI
Name Bioanalytical Systems Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-09-30
Latest Fiscal Revenue $26,346,000
Latest Fiscal EPS $-0.02
Price Info
21 Day Moving Average $3.7907
21 Day EMA $3.741840
50 Day Moving Average $3.2769
50 Day EMA $3.344040
200 Day EMA $2.429950
200 Day Moving Average 2.185250
52 Week High $4.44
52 Week Low $1.18
52 Week Change $182.867100
Alpha 0.017494
Beta 0.7506
Standard Deviation 0.183005
R2 0.019838
Periods 60
Share Information
10 Day Average Volume 38,831
20 Day Average Volume 69,090
30 Day Average Volume 91,384
50 Day Average Volume 77,195
Outstanding Shares 10,496,788
Float Shares 9,633,063
Percent Float 91.77%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 28
Institute Holdings Date 2019-09-30
Institute Bought Previous 3 Months 22,552
Institute Holdings Percent 7.900000
Institute Sold Previous 3 Months 275
Insider Holdings Date 2019-08-31
Insider Bought Previous 3 Months 10
Insider Holdings Percent 8.20%
Insider Sold Previous 3 Months -
Insiders Shares Owned 863,725
Price Change
7 Day Price Change $0.3650000
7 Day Percent Change 9.92%
21 Day Price Change $0.3550000
21 Day Percent Change 9.62%
30 Day Price Change $0.4550002
30 Day Percent Change 12.67%
Month To Date Price Change $0.4550
Month To Date Percent 12.67%
90 Day Price Change $2.065000
90 Day Percent Change 104.29%
Quarter To Date $0.455000
Quarter To Date Percent 12.67%
180 Day Price Change $2.015000
180 Day Percent Change 99.26%
200 Day Price Change $1.965000
200 Day Percent Change 94.47%
Year To Date $2.775000
Year To Date Percent 218.50%
Profile
Description Bioanalytical Systems Inc is a contract research organization which provides drug discovery and development services and analytical instruments. The company operates in two business segments namely contract research services and research products. The contract research services segment provides research and development support on a contract basis directly to pharmaceutical companies. In addition, it also includes services to screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance and quality control testing. The research products segment provides liquid chromatography, electrochemical and physiological monitoring products to pharmaceutical companies, universities, government research centers, and medical research institutions.
Details
Issue Type CS
Market Cap $42,459,507
Sec Type EQS
Auditor RSM US LLP
Total Shares Outstanding 10,496,788
CEO Robert Leasure
Employees 235
Last Audit UQ
Classification
CIK 0000720154
Industry Medical Diagnostics & Research
Sector Healthcare
NAICS Pharmaceutical Preparation Manufacturing(325412)
Info
Address 2701 Kent Avenue
West Lafayette, IN 47906
Website http://www.basinc.com
Facisimile +1 765 497-1102
Telephone +1 765 463-4527
Email
Key Ratios
Profitability
EBIT Margin -1.9
EBITDA Margin 5.4
Pre-Tax Profit Margin -1.8
Profit Margin Cont -3.75
Gross Margin 29.80
Profit Margin TOT -3.75
Income Statements
Revenue $28,830,000
Revenue Per Share $2.7466
Revenue 3 Years $10.98
Revenue 5 Years $3.19
Valuation Measures
PE Ratio -
Enterprise Value $51,594,468
Price To Sales 1.472754
Price To Free Cash -8.5
PE High Last 5 Years -
Price To Book 3.5
Price To Cash Flow 12.4
PE Low Last 5 Years -
Price To Tangible Book 9.7
Financial Strength
Total Debt To Equity 1.4
Int Coverage -1.3
Current Ratio 0.7
Leverage Ratio 3.2
Quick Ratio 0.5
Long Term Debt To Capital 0.54
Assets
Receivables Turnover 2.6
Invoice Turnover 23.10
Assets Turnover 0.40
Management Effectiveness
Return Assets -4.25
Return On Equity -13.59
Return On Capital -3.88
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
BASI
Bioanalyti..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.